2021
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Halatsch, M.E. and Kast, R.E. and Karpel-Massler, G. and Mayer, B. and Zolk, O. and Schmitz, B. and Scheuerle, A. and Maier, L. and Bullinger, L. and Mayer-Steinacker, R. and Schmidt, C. and Zeiler, K. and Elshaer, Z. and Panther, P. and Schmelzle, B. and Hallmen, A. and Dwucet, A. and Siegelin, M.D. and Westhoff, M.A. and Beckers, K. and Bouche, G. and Heiland, T.
Neuro-Oncology Advances 3
(1): vdab075.
7 August 2021
2020
Long-lived tumor-associated macrophages in glioma.
Georgieva, P.B. and Mathivet, T. and Alt, S. and Giese, W. and Riva, M. and Balcer, M. and Gerhardt, H.
Neuro-Oncology Advances 2
(1): vdaa127.
9 November 2020
This list was generated on Fri Apr 26 02:28:15 2024 CEST.